NCT03192826View on ClinicalTrials.gov

Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 20, 2016

Primary Completion Date

July 8, 2017

Study Completion Date

July 8, 2017

Conditions

Posterior Capsule OpacificationOcular Hypertension

Interventions

DRUG

Brinzolamide/Brimonidine FC

1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy

DRUG

Brimonidine 0.2%

1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy

DRUG

Artificial tears

1 drop of artificial tears 1 hour before Nd-YAG capsulotomy

Trial Locations (1)

26504

University Hospital of Patras, Pátrai

All Listed Sponsors

lead

University Hospital of Patras

OTHER

NCT03192826 - Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy | Biotech Hunter | Biotech Hunter